EdgarLookup
4

PRIMARY DOCUMENT

Company
GT Biopharma, Inc.
Filed
May 14, 2020
Period of Report
May 13, 2020
Accession Number
0000939798-20-000006
View Document ↗ View on SEC.gov ↗